DOI: 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde

References

Stebbing J, Baranau YV, Baryash V. et al.
Double-blind, randomized phase III study to compare the efficacy and safety of CT-P6, trastuzumab biosimilar candidate versus trastuzumab as neoadjuvant treatment in HER2 positive early breast cancer (EBC).

J Clin Oncol 2017;
35: 510

Download Bibliographical Data

Search in:
Access: